Takeda Pharmaceutical
TAK
#489
Rank
A$71.21 B
Marketcap
A$21.40
Share price
0.28%
Change (1 day)
1.98%
Change (1 year)

Takeda Pharmaceutical (TAK) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$74.62 Billion

According to Takeda Pharmaceutical's latest financial reports the company's total liabilities are A$74.62 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Takeda Pharmaceutical - Total liabilities on balance sheet (from 2008 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-03-31A$78.14 B-1.35%
2024-03-31A$79.21 B-6.96%
2023-03-31A$85.13 B3.62%
2022-03-31A$82.15 B-10.67%
2021-03-31A$91.97 B-25.03%
2020-03-31A$122.67 B12.54%
2019-03-31A$109.00 B326.18%
2018-03-31A$25.57 B-9.26%
2017-03-31A$28.18 B34.13%
2016-03-31A$21.01 B-8.12%
2015-03-31A$22.87 B7.86%
2014-03-31A$21.20 B21.43%
2013-03-31A$17.46 B4.43%
2012-03-31A$16.72 B121.7%
2011-03-31A$7.54 B-1.04%
2010-03-31A$7.62 B-25.59%
2009-03-31A$10.24 B83.19%
2008-03-31A$5.59 B-12.99%
2007-03-31A$6.42 B-23%
2006-03-31A$8.34 B27.62%
2005-03-31A$6.53 B-7.85%
2004-03-31A$7.09 B2.56%
2003-03-31A$6.91 B-9.72%
2002-03-31A$7.66 B-5.75%
2001-03-31A$8.13 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
A$170.87 B 128.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$99.37 B 33.16%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
A$174.03 B 133.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$94.11 B 26.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
A$1.63 B-97.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
A$3.04 B-95.92%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
A$121.18 B 62.39%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$92.23 B 23.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
A$116.84 B 56.57%๐Ÿ‡บ๐Ÿ‡ธ USA